Medicare Proposes To Cover Biogen's Controversial Alzheimer's Drug With Restrictions

CBS Local Boston

Jan 12, 2022

(CNN) --- Medicare has proposed covering the controversial and costly Alzheimer's drug Aduhelm only for those enrolled in qualifying clinical trials, the Centers for Medicare and M…